Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Association of low-energy femoral fractures with prolonged bisphosphonate use: a case--control study.

Literature DB >> 19436933

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case--control study.

S D Vasikaran.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2009 PMID： 19436933 DOI： 10.1007/s00198-009-0955-5

Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507

× No keyword cloud information.

11 in total

1. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

Authors: Brett A Lenart; Dean G Lorich; Joseph M Lane
Journal: N Engl J Med Date: 2008-03-20 Impact factor: 91.245

2. Management of myeloma with bisphosphonates.

Authors: R Bataille
Journal: N Engl J Med Date: 1996-02-22 Impact factor: 91.245

3. Subtrochanteric Femoral Insufficiency Fracture Following Bisphosphonate Therapy for Osseous Metastases.

Authors: Lisabeth A Bush; Felix S Chew
Journal: Radiol Case Rep Date: 2015-12-07

4. Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid.

Authors: Greg Wernecke; Surena Namdari; Surena Namduri; Edward F DiCarlo; Robert Schneider; Joseph Lane
Journal: HSS J Date: 2008-07-16

5. Severely suppressed bone turnover and atypical skeletal fragility.

Authors: Maja Visekruna; Deborah Wilson; Fergus Eoin McKiernan
Journal: J Clin Endocrinol Metab Date: 2008-06-03 Impact factor: 5.958

6. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.

Authors: Noopur Raje; Sook-Bin Woo; Karen Hande; Jeffrey T Yap; Paul G Richardson; Sonia Vallet; Nathaniel Treister; Teru Hideshima; Niall Sheehy; Shweta Chhetri; Brendan Connell; Wanling Xie; Yu-Tzu Tai; Agnieszka Szot-Barnes; Mei Tian; Robert L Schlossman; Edie Weller; Nikhil C Munshi; Annick D Van Den Abbeele; Kenneth C Anderson
Journal: Clin Cancer Res Date: 2008-04-15 Impact factor: 12.531

7. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.

Authors: Robert A Kyle; Gary C Yee; Mark R Somerfield; Patrick J Flynn; Susan Halabi; Sundar Jagannath; Robert Z Orlowski; David G Roodman; Patricia Twilde; Kenneth Anderson
Journal: J Clin Oncol Date: 2007-05-21 Impact factor: 44.544

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case--control study.

1. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

2. Management of myeloma with bisphosphonates.

3. Subtrochanteric Femoral Insufficiency Fracture Following Bisphosphonate Therapy for Osseous Metastases.

4. Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid.

5. Severely suppressed bone turnover and atypical skeletal fragility.

6. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.

7. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.

8. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

9. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.

10. High concentrations of pamidronate in bone weaken the mechanical properties of intact femora in a rat model.

1. Impact and risk factors of post-stroke bone fracture.

2. Acute nontraumatic clavicle fracture associated with long-term bisphosphonate therapy.

3. A case report of long-term bisphosphonate therapy and atypical stress fracture of bilateral femur.